Company news
Avacta Group PLC news in 2018
Avacta Group PLC's news releases, calls and decks from 2018, newest first.
Avacta London Science Day
December 17, 2018
Appointment of Chief Medical Officer
December 12, 2018
Avacta (AVCT): Wake-up call for the market
December 10, 2018
Development Partnership with LG Chem Life Sciences
December 10, 2018
Avacta to Present at Major European Conference
November 12, 2018
Avacta's CTO to Present at Major US Conference
October 11, 2018
Avacta agrees Affimer reagent licensing deal
October 10, 2018
Investor Meeting and Presentation
September 21, 2018
Avacta (AVCT): Capital increase for further dev...
September 5, 2018
Results of Placing and Subscription
July 30, 2018
Proposed Placing and Subscription to raise £11.4m
July 30, 2018
Avacta (AVCT): Ground-breaking new drug conjuga...
July 30, 2018
Major Therapeutics Co-development Partnership
July 24, 2018
Avacta (AVCT): Gearing up the management team
June 26, 2018
Appointment of Non-Executive Chairman
June 11, 2018
Avacta (AVCT): In vivo expression of Affimers
May 31, 2018
Successful Outcome of Study with FIT Biotech
May 22, 2018
Avacta (AVCT): Commendable rate of progress
April 17, 2018
Avacta to Present at Investor Forum
March 29, 2018
Summary of Capital Markets Day
February 8, 2018
Avacta and OncoSec to Collaborate
January 22, 2018
HardmanResearch: Affimer Drug Conjugates a reality
January 15, 2018
Drug Development Partnership with Glythera
January 15, 2018
Capital Markets Day Notification
January 8, 2018
PDMR Dealing and Issue of Equity
January 4, 2018
Presenting at the Biotech Showcase, San Francisco
January 3, 2018